James L. Tyree - May 20, 2022 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Stock symbol
CCXI
Transactions as of
May 20, 2022
Transactions value $
$0
Form type
4
Date filed
5/24/2022, 08:18 PM
Previous filing
May 16, 2022
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Options Exercise $0 +7.73K +50.58% $0.00 23K May 20, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Restricted Stock Units Options Exercise -7.73K -100% 0 May 20, 2022 Common Stock 7.73K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021.
F2 Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F3 100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.